<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0003-3170</journal-id>
<journal-title><![CDATA[Angiología]]></journal-title>
<abbrev-journal-title><![CDATA[Angiología]]></abbrev-journal-title>
<issn>0003-3170</issn>
<publisher>
<publisher-name><![CDATA[Arán Ediciones S.L.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0003-31702022000400010</article-id>
<article-id pub-id-type="doi">10.20960/angiologia.00395</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Reconstrucción endovascular de la bifurcación aortoilíaca: técnica CERAB]]></article-title>
<article-title xml:lang="en"><![CDATA[CERAB (covered endovascular reconstruction of aortic bifurcation)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Fajardo]]></surname>
<given-names><![CDATA[José A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario 12 de Octubre Servicio de Angiología, Cirugía Vascular y Endovascular ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<volume>74</volume>
<numero>4</numero>
<fpage>195</fpage>
<lpage>197</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0003-31702022000400010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0003-31702022000400010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0003-31702022000400010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Según el Trans-Atlantic Inter-Society Consensus (TASC II), el bypass de derivación (cirugía abierta) es el tratamiento de elección para la enfermedad oclusiva aortoilíaca extensa (AIOD) debido a las buenas tasas de permeabilidad a largo plazo. Sin embargo, la reconstrucción quirúrgica se asocia con morbilidad y mortalidad perioperatorias. La técnica de kissing stent se introdujo como una alternativa de tratamiento endovascular para la enfermedad oclusiva aortoilíaca bilateral en 1991. Las tasas de éxito técnico reportadas variaron con el uso de stents metálicos AOID extensa. El ensayo COBEST mostró que los stents cubiertos expandibles con balón (CBES) tenían una tasa de permeabilidad primaria superior y un mejor resultado clínico a los 24 meses en comparación con los stents de metal simples. CBES podía, por tanto, reducir inmediatamente el riesgo de complicaciones del procedimiento, como la disección, la perforación, la estenosis del stent y la embolización. En 2013 se introdujo la técnica CERAB (Covered Endovascular Reconstruction of Aortic Bifurcation) para mejorar los resultados del tratamiento endovascular mediante una reconstrucción más anatómica y fisiológica, con un mejor resultado clínico posterior. La técnica CERAB se desarrolló para superar las desventajas anatómicas y fisiológicas de los kissing stents, como las alteraciones del flujo que provocan turbulencia y estasis de sangre, lo que puede provocar la formación de trombos y neohiperplasia de la íntima. Las ventajas de esta técnica son: Es un procedimiento mínimamente invasivo frente a la cirugía abierta. Es aplicable para casi todos los pacientes con patología aortoilíaca. Tiene un menor riesgo de complicaciones al usar stent cubiertos. Corta estancia hospitalaria dada la rápida recuperación posoperatoria. Los primeros resultados de la configuración CERAB son prometedores a un año de seguimiento en un grupo de 130 pacientes con AOID y la tasa de complicaciones mayores a 30 días fue del 7,7 %. Se desconocen todavía los resultados a largo plazo de seguimiento. La técnica CERAB puede cambiar el algoritmo de tratamiento de la enfermedad aortoilíaca extensa. Según los datos comunicados parece ser una alternativa segura y factible con resultados prometedores y puede ser una alternativa válida para la cirugía.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract According to the Trans-Atlantic Inter-Society Consensus (TASC II) bypass grafting is the treatment of choice for extensive aortoiliac occlusive disease (AIOD) due to the good long-term patency rates. However, surgical reconstruction is associated with perioperative morbidity and mortality. Kissing stent technique was introduced as an endovascular treatment alternative for bilateral aortoiliac occlusive disease in 1991. Reported technical success rates varied with the use of bare metal stents in extensive AOID. The COBEST trial showed that covered balloon expandable stents (CBES) have a superior primary patency rate and clinical improvement outcome at 24 months when compared with bare metal stents. CBES may immediately reduce the risk of procedural complications such as dissection, perforation, in-stent stenosis, and embolization. In 2013 the Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) technique was introduced to improve endovascular treatment results by a more anatomical and physiological reconstruction, with a subsequent better clinical outcome. The CERAB technique was developed to overcome the anatomical and physiological disadvantages of kissing stents such as flow disturbances leading to turbulence and stasis of blood, which may cause thrombus formation and intimal neohyperplasia. The advantages of this technique are: It is a minimally invasive procedure compared to open surgery. Applicable for almost all patients with aortoiliac pathology. Lower risk of complications when using covered stents. Short hospital stays, given rapid postoperative recovery. The early results of the CERAB configuration are promising at 1-year follow-up in a group of 130 patients with AOID and the 30-day major complication rate was 7.7 %. Long-term follow-up results are still unknown. CERAB may change the treatment algorithm of AIOD and juxtarenal occlusive disease. It appears to be a safe and feasible alternative with promising results, which makes it a valid alternative for surgery.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[CERAB]]></kwd>
<kwd lng="es"><![CDATA[Técnica]]></kwd>
<kwd lng="es"><![CDATA[Reconstrucción]]></kwd>
<kwd lng="es"><![CDATA[Endovascular]]></kwd>
<kwd lng="en"><![CDATA[Pelvic varices]]></kwd>
<kwd lng="en"><![CDATA[Embolization]]></kwd>
<kwd lng="en"><![CDATA[Pelvic pain]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goverde]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Grimme]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Verbruggen]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Reijnen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Covered endovascular reconstruction of aortic bi-furcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease]]></article-title>
<source><![CDATA[J Cardio-vasc Surg (Torino)]]></source>
<year>2013</year>
<volume>54</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>383-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grimme]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Goverde]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[Oostayen JA]]></given-names>
</name>
<name>
<surname><![CDATA[Zeebregts]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Reijnen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Covered stents for aortoiliac re-construction of chronic occlusive lesions]]></article-title>
<source><![CDATA[J Cardiovasc Surg (Torino)]]></source>
<year>2012</year>
<volume>53</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>279-89</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grimme]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Goverde]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Verbruggen]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zeebregts]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Reijnen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editor's Choice--First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CE-RAB) Technique for Aortoiliac Occlusive Disease]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2015</year>
<volume>50</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>638-47</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grimme]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Reijnen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Pfister]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Martens]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Kasprzak]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polytetrafluoroethylene covered stent place-ment for focal occlusive disease of the infrarenal aorta]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2014</year>
<volume>48</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>545-50</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grimme]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Spithoven]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Zeebregts]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Scharn]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Reijnen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Midterm outcome of balloon-expandable polytetrafluoroethylene-covered stents in the treatment of iliac artery chronic occlusive di-sease]]></article-title>
<source><![CDATA[J Endovasc Ther]]></source>
<year>2012</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>797-804</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mwipatayi]]></surname>
<given-names><![CDATA[BP]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Temple]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Vijayan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<collab>Covered Versus Balloon Expan-dable Stent Trial (COBEST)</collab>
<article-title xml:lang=""><![CDATA[A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease]]></article-title>
<source><![CDATA[J Vasc Surg]]></source>
<year>2011</year>
<volume>54</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1561-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sabri]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Choudhri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Orgera]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Arslan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Turba]]></surname>
<given-names><![CDATA[UC]]></given-names>
</name>
<name>
<surname><![CDATA[Harthun]]></surname>
<given-names><![CDATA[NL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes of covered kissing stent placement compared with bare metal stent placement in the treatment of atherosclerotic occlusive di-sease at the aortic bifurcation]]></article-title>
<source><![CDATA[J Vasc Interv Radiol]]></source>
<year>2010</year>
<volume>21</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>995-1003</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saker]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Oppat]]></surname>
<given-names><![CDATA[WF]]></given-names>
</name>
<name>
<surname><![CDATA[Kent]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Ryu]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Chrisman]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Nemcek]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early failure of aortoiliac kissing stents: histopathologic correlation]]></article-title>
<source><![CDATA[J Vasc Interv Radiol]]></source>
<year>2000</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>333-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taeymans]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Goverde]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lauwers]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Verbruggen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The CERAB technique: tips, tricks and results]]></article-title>
<source><![CDATA[J Cardio-vasc Surg (Torino)]]></source>
<year>2016</year>
<volume>57</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>343-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
